BioStem Technologies, Inc.
BSEM
$4.38
-$0.46-9.60%
OTC PK
| 06/30/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.59% | 7.30% | 30.25% | 16.56% | 92.93% |
| Total Depreciation and Amortization | 15.49% | 11.07% | 95.09% | -5.21% | 72.25% |
| Total Amortization of Deferred Charges | -33.51% | 8.66% | 491.12% | -19.06% | 340.31% |
| Total Other Non-Cash Items | 21.98% | -274.60% | -150.03% | 44.24% | -58.67% |
| Change in Net Operating Assets | 240.29% | 416.78% | 231.08% | 49.19% | 74.88% |
| Cash from Operations | 33.10% | 49.01% | 50.09% | 1,029.08% | 1,045.27% |
| Capital Expenditure | -101.82% | 24.75% | 23.25% | -1,190.32% | -1,216.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.82% | -741.18% | -758.00% | -1,190.32% | -1,216.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -803.34% | 43.73% | 32.47% | 45.76% | 34.28% |
| Issuance of Common Stock | -100.00% | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,242.48% | 82.94% | 79.53% | -49.86% | -84.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.58% | 35.63% | 35.63% | 1,368.28% | 1,368.28% |